journal article·2026-06

CD4 + Th Cell‐Derived Extracellular Vesicles Orchestrate CD8 + T Cells and Eosinophils to Enhance Anti‐Tumor Immunity

Zhaoxin Yang, Tianyu Lan, Rui Diao, Zhirang Zhang, Yumeng Ma, Xiaozhou Zhang, Yongting Feng, Yanjun Chen, Yuan Li, Yuting Wei, Wenli Fang, Zhangyan Jing, Aihui Fan, Jinqiang Wang, Xin Liang, Xudong Zhang

Small· Volume 22· Issue 36
Publisher page

Abstract

ABSTRACT CD4 + T cells play a pivotal role in anti‐tumor immunity by assisting CD8 + T cells in eliminating MHC I + tumor cells and promoting immune responses against MHC‐deficient tumors through myeloid‐cell recruitment. Extracellular vesicles (EVs) are increasingly recognized as important mediators of intercellular immune communication; however, how CD4 + T helper (Th)‐derived EVs modulate tumor immune cells, including CD8 + T cells and eosinophils, to orchestrate anti‐tumor responses remains poorly understood. Here, we show that immune checkpoint molecules, including PD‐1 and TIM‐3, and the cytokine IL‐5 are enriched on CD4 + Th cell microvilli and EVs. Activated CD4 + Th cells released both exosomes and ectosomes, which cooperatively suppressed tumor progression through two complementary mechanisms. First, CD4 + Th‐derived exosomes and ectosomes displayed immune checkpoint receptors such as PD‐1 and TIM‐3 on their surface, thereby intercepting tumor‐derived inhibitory signals, reversing T cell exhaustion, and enhancing cytotoxic T cell activity. Second, CD4 + Th‐derived EVs carried IL‐5 and other effector molecules that promoted JAK–STAT signaling, eosinophil recruitment to tumor sites, and eosinophil‐mediated tumor cell killing through degranulation. Moreover, CD4 + Th‐derived EVs remodeled the tumor microenvironment by enhancing CD8 + T cell and eosinophil infiltration and activation, suggesting their potential role in immune regulation and cancer therapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · Immune cells in cancer · Neutrophil, Myeloperoxidase and Oxidative Mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmacology, Molecular Cancer Research Center School of Medicine Shenzhen Campus of Sun Yat‐Sen University Sun Yat‐Sen University Shenzhen Guangdong China

Department of Physiology School of Basic Medicine; The Affiliated Dongguan Songshan Lake Central Hospital Guangdong Medical University Dongguan Guangdong China

Key Laboratory of Advanced Drug Delivery Systems of Zhejiang Province, College of Pharmaceutical Sciences Zhejiang University Hangzhou Zhejiang China

Key Laboratory of Regenerative Medicine Of Ministry of Education Jinan University Guangzhou Guangdong China

Funding

National Natural Science Foundation of China

References (64)

Show source-provided references
1. 10.1038/s41416‐020‐01048‐410.1038/s41416‐020‐01048‐4 ↗
2. 10.1016/j.trecan.2023.07.01310.1016/j.trecan.2023.07.013 ↗
3. 10.1038/s43018‐023‐00521‐210.1038/s43018‐023‐00521‐2 ↗
4. 10.1016/j.cell.2020.05.01710.1016/j.cell.2020.05.017 ↗
5. 10.4049/jimmunol.110181210.4049/jimmunol.1101812 ↗
6. 10.1038/s41586‐020‐2611‐310.1038/s41586‐020‐2611‐3 ↗
7. 10.1016/j.cell.2015.08.00410.1016/j.cell.2015.08.004 ↗
8. 10.1158/0008‐5472.Can‐10‐132210.1158/0008‐5472.Can‐10‐1322 ↗
9. 10.1038/nature0479010.1038/nature04790 ↗
10. 10.1080/2162402x.2016.121900910.1080/2162402x.2016.1219009 ↗
11. 10.4049/jimmunol.100084410.4049/jimmunol.1000844 ↗
12. 10.1038/s41586‐023‐06199‐x10.1038/s41586‐023‐06199‐x ↗
13. 10.1016/j.ccell.2022.11.01410.1016/j.ccell.2022.11.014 ↗
14. 10.7150/ijbs.469410.7150/ijbs.4694 ↗
15. 10.1016/j.bbamcr.2014.06.01410.1016/j.bbamcr.2014.06.014 ↗
16. 10.1038/s41577‐021‐00566‐310.1038/s41577‐021‐00566‐3 ↗
17. 10.1126/sciadv.abe334810.1126/sciadv.abe3348 ↗
18. Axelrod M. L. · 2019 · 2392
19. 10.1038/s41586‐022‐04682‐510.1038/s41586‐022‐04682‐5 ↗
20. 10.1080/20013078.2018.153575010.1080/20013078.2018.1535750 ↗
21. 10.1038/s41577‐022‐00763‐810.1038/s41577‐022‐00763‐8 ↗
22. 10.3389/fimmu.2021.77155110.3389/fimmu.2021.771551 ↗
23. 10.1016/j.nantod.2022.10160610.1016/j.nantod.2022.101606 ↗
24. 10.1038/s41388‐021‐01896‐110.1038/s41388‐021‐01896‐1 ↗
25. 10.1038/s41467‐018‐06090‐810.1038/s41467‐018‐06090‐8 ↗
26. 10.7554/eLife.4752810.7554/eLife.47528 ↗
27. 10.1002/advs.20180221910.1002/advs.201802219 ↗
28. 10.1016/j.biomaterials.2022.12176510.1016/j.biomaterials.2022.121765 ↗
29. 10.1007/978-3-030-49270-0_110.1007/978-3-030-49270-0_1 ↗
30. 10.1038/s41467‐018‐06090‐810.1038/s41467‐018‐06090‐8 ↗
31. 10.1073/pnas.78.2.115710.1073/pnas.78.2.1157 ↗
32. 10.2337/db23‐098710.2337/db23‐0987 ↗
33. 10.1073/pnas.160539911310.1073/pnas.1605399113 ↗
34. 10.1038/s41598‐018‐27190‐x10.1038/s41598‐018‐27190‐x ↗
35. 10.4161/onci.2089710.4161/onci.20897 ↗
36. 10.1002/cncr.282069052910.1002/cncr.2820690529 ↗
37. 10.1007/s11882‐016‐0634‐510.1007/s11882‐016‐0634‐5 ↗
38. 10.1038/nri.2017.9510.1038/nri.2017.95 ↗
39. 10.1038/nm.185510.1038/nm.1855 ↗
40. 10.1177/204062231560925110.1177/2040622315609251 ↗
41. 10.1172/jci.insight.13616610.1172/jci.insight.136166 ↗
42. 10.1158/0008‐5472.Can‐10‐172210.1158/0008‐5472.Can‐10‐1722 ↗
43. 10.1080/20013078.2019.165045810.1080/20013078.2019.1650458 ↗
44. 10.1038/s41416‐022‐02056‐210.1038/s41416‐022‐02056‐2 ↗
45. 10.1158/0008‐5472.Can‐16‐121910.1158/0008‐5472.Can‐16‐1219 ↗
46. 10.1084/jem.188.12.235710.1084/jem.188.12.2357 ↗
47. 10.1084/jem.2002168310.1084/jem.20021683 ↗
48. 10.1080/2162402x.2017.139313410.1080/2162402x.2017.1393134 ↗
49. 10.4049/jimmunol.178.7.422210.4049/jimmunol.178.7.4222 ↗
50. 10.1158/2326‐6066.Cir‐18‐049410.1158/2326‐6066.Cir‐18‐0494 ↗
51. 10.1089/dna.2004.23.54910.1089/dna.2004.23.549 ↗
52. 10.1080/2162402x.2017.131742010.1080/2162402x.2017.1317420 ↗
53. 10.4049/jimmunol.100044610.4049/jimmunol.1000446 ↗
54. 10.3390/cancers1111166410.3390/cancers11111664 ↗
55. 10.4049/jimmunol.174.1.11010.4049/jimmunol.174.1.110 ↗
56. 10.1038/ni.315910.1038/ni.3159 ↗
57. 10.1016/j.jaci.2009.04.03110.1016/j.jaci.2009.04.031 ↗
58. 10.1002/jev2.1215210.1002/jev2.12152 ↗
59. 10.3390/ijms2021546810.3390/ijms20215468 ↗
60. 10.1016/j.jcmgh.2023.08.00510.1016/j.jcmgh.2023.08.005 ↗
61. 10.4049/jimmunol.110127010.4049/jimmunol.1101270 ↗
62. 10.1158/1078‐0432.Ccr‐15‐067610.1158/1078‐0432.Ccr‐15‐0676 ↗
63. 10.1158/1078‐0432.Ccr‐15‐241210.1158/1078‐0432.Ccr‐15‐2412 ↗
64. 10.4110/in.2023.23.e2910.4110/in.2023.23.e29 ↗